These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 24012497

  • 1. LINE-1 ORF-1p functions as a novel HGF/ETS-1 signaling pathway co-activator and promotes the growth of MDA-MB-231 cell.
    Yang Q, Feng F, Zhang F, Wang C, Lu Y, Gao X, Zhu Y, Yang Y.
    Cell Signal; 2013 Dec; 25(12):2652-60. PubMed ID: 24012497
    [Abstract] [Full Text] [Related]

  • 2. Long interspersed nucleotide acid element-1 ORF-1 protein promotes proliferation and invasion of human colorectal cancer LoVo cells through enhancing ETS-1 activity.
    Li MY, Zhu M, Feng F, Cai FY, Fan KC, Jiang H, Wang ZQ, Linghu EQ.
    Genet Mol Res; 2014 Apr 14; 13(3):6981-94. PubMed ID: 24782214
    [Abstract] [Full Text] [Related]

  • 3. LINE-1 ORF-1p functions as a novel androgen receptor co-activator and promotes the growth of human prostatic carcinoma cells.
    Lu Y, Feng F, Yang Y, Gao X, Cui J, Zhang C, Zhang F, Xu Z, Qv J, Wang C, Zeng Z, Zhu Y, Yang Y.
    Cell Signal; 2013 Feb 14; 25(2):479-89. PubMed ID: 23153584
    [Abstract] [Full Text] [Related]

  • 4. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K, Hashimoto T, Kitamura N, Tanaka T.
    Mol Cancer Res; 2009 Jul 14; 7(7):1179-88. PubMed ID: 19567783
    [Abstract] [Full Text] [Related]

  • 5. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH.
    Toxicol Appl Pharmacol; 2008 Jan 15; 226(2):178-91. PubMed ID: 17961621
    [Abstract] [Full Text] [Related]

  • 6. Microenvironment Stimuli HGF and Hypoxia Differently Affected miR-125b and Ets-1 Function with Opposite Effects on the Invasiveness of Bone Metastatic Cells: A Comparison with Breast Carcinoma Cells.
    Matteucci E, Maroni P, Nicassio F, Ghini F, Bendinelli P, Desiderio MA.
    Int J Mol Sci; 2018 Jan 16; 19(1):. PubMed ID: 29337876
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ets-1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environment.
    Furlan A, Vercamer C, Desbiens X, Pourtier A.
    J Cell Physiol; 2008 Jun 16; 215(3):782-93. PubMed ID: 18181172
    [Abstract] [Full Text] [Related]

  • 10. Diacylglycerol kinase is required for HGF-induced invasiveness and anchorage-independent growth of MDA-MB-231 breast cancer cells.
    Filigheddu N, Cutrupi S, Porporato PE, Riboni F, Baldanzi G, Chianale F, Fortina E, Piantanida P, De Bortoli M, Vacca G, Graziani A, Surico N.
    Anticancer Res; 2007 Jun 16; 27(3B):1489-92. PubMed ID: 17595766
    [Abstract] [Full Text] [Related]

  • 11. Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis.
    Li DQ, Hou YF, Wu J, Chen Y, Lu JS, Di GH, Ou ZL, Shen ZZ, Ding J, Shao ZM.
    Eur J Cancer; 2006 Dec 16; 42(18):3274-86. PubMed ID: 16979889
    [Abstract] [Full Text] [Related]

  • 12. TGFβ1 regulates HGF-induced cell migration and hepatocyte growth factor receptor MET expression via C-ets-1 and miR-128-3p in basal-like breast cancer.
    Breunig C, Erdem N, Bott A, Greiwe JF, Reinz E, Bernhardt S, Giacomelli C, Wachter A, Kanthelhardt EJ, Beißbarth T, Vetter M, Wiemann S.
    Mol Oncol; 2018 Sep 16; 12(9):1447-1463. PubMed ID: 30004628
    [Abstract] [Full Text] [Related]

  • 13. CREB-1 and AP-1 transcription factors JunD and Fra-2 regulate bone sialoprotein gene expression in human breast cancer cells.
    Detry C, Lamour V, Castronovo V, Bellahcène A.
    Bone; 2008 Feb 16; 42(2):422-31. PubMed ID: 18088579
    [Abstract] [Full Text] [Related]

  • 14. Defining ETS transcription regulatory networks and their contribution to breast cancer progression.
    Turner DP, Findlay VJ, Moussa O, Watson DK.
    J Cell Biochem; 2007 Oct 15; 102(3):549-59. PubMed ID: 17661355
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
    Xu H, Washington S, Verderame MF, Manni A.
    Breast Cancer Res Treat; 2008 Nov 15; 112(2):255-61. PubMed ID: 18097746
    [Abstract] [Full Text] [Related]

  • 18. Estrogen receptor α enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent manner.
    Cao P, Feng F, Dong G, Yu C, Feng S, Song E, Shi G, Liang Y, Liang G.
    BMC Cancer; 2015 Jun 30; 15():491. PubMed ID: 26122040
    [Abstract] [Full Text] [Related]

  • 19. Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma.
    Maroni P, Matteucci E, Luzzati A, Perrucchini G, Bendinelli P, Desiderio MA.
    Breast Cancer Res Treat; 2011 Sep 30; 129(2):433-50. PubMed ID: 21069452
    [Abstract] [Full Text] [Related]

  • 20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 30; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.